Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

17 results
Display

Lynch syndrome – Muir-Torre variant: implication in gynecologic oncology

Bogani G, Leone Roberti Maggiore U, Raspagliesi F

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube

Choi MC, Bae JS, Jung SG, Park H, Joo WD, Song SH, Lee C, Kim JH, Lee KC, Lee S, Lee JH

The original article contained errors.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer

Jalloul RJ, Nick AM, Munsell MF, Westin SN, Ramirez PT, Frumovitz , Soliman PT

OBJECTIVE: To determine the effect of surgeon experience on intraoperative, postoperative and long-term outcomes among patients undergoing pelvic exenteration for gynecologic cancer. METHODS: This was a retrospective analysis of all women...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer

Matsuo K, Machida H, Mariani A, Mandelbaum RS, Glaser GE, Gostout BS, Roman LD, Wright JD

OBJECTIVE: To examine the trends and survival for women with early-stage epithelial ovarian cancer who underwent adequate lymphadenectomy during surgical treatment. METHODS: This is a retrospective observational study examining the Surveillance,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Negative peritoneal washing cytology during interval debulking surgery predicts overall survival after neoadjuvant chemotherapy for ovarian cancer

Iura A, Takita M, Kawano A, Imai K, Konnai K, Onose R, Kato H

OBJECTIVE: Optimal debulking in interval debulking surgery (IDS) after neoadjuvant chemotherapy (NAC) has been reported as a prognostic factor for patients with ovarian cancer. However, the identification of microscopic residual...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131)

Nishio S, Aihara S, Shimokawa , Fujishita , Taniguchi , Hachisuga , Yanazume S, Kobayashi , Murakami F, Numa F, Kotera K, Okura N, Toki N, Yokoyama M, Ushijima K

OBJECTIVE: Palonosetron is effective for the management of acute and delayed chemotherapy-induced nausea and vomiting (CINV). While emetogenic carboplatin-based chemotherapy is widely used to treat gynecologic cancers, few studies have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer

Bogani G, Rossetti D, Ditto A, Martinelli F, Chiappa V, Mosca L, Leone Roberti Maggiore U, Ferla S, Lorusso D, Raspagliesi F

OBJECTIVE: Accumulating evidence support that complete cytoreduction (CC) at the time of secondary cytoreductive surgery (SCS) improves survival in patients affected by recurrent ovarian cancer (ROC). Here, we aimed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources

Tantivatana T, Rongsriyam K

OBJECTIVE: To determine and compare treatment outcomes between cobalt-60 (Co-60) and iridium-192 (Ir-192) high dose rate (HDR) brachytherapy in stage IB2–IIIB cervical cancer patients at Department of Radiology, Faculty of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study

Fu HC, Chen JR, Chen MY, Hsu KF, Cheng WF, Chiang AJ, Ke YM, Chen YC, Chang YY, Huang CY, Kang CY, Kan YY, Hsiao SM, Yen MS

OBJECTIVE: Choice of hysterectomy and adjuvant treatment for International Federation of Gynecology and Obstetrics (FIGO) 2009 stage II endometrioid endometrial cancer (EEC) is still controversial. Aims of this study were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Teenage pregnancy complicated by primary invasive ovarian cancer: association for oncologic outcome

Blake EA, De Zoysa M, Morocco EB, Kaiser SB, Kodama M, Grubbs BH, Matsuo K

OBJECTIVE: To examine survival of teenage women with pregnancies complicated by primary ovarian cancer. METHODS: This is a secondary analysis of a previously organized systematic literature review of primary ovarian cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study

Feng Z, Wen H, Jiang Z, Liu S, Ju X, Chen X, Xia L, Xu J, Bi R, Wu X

OBJECTIVE: To present the surgical outcomes of advanced epithelial ovarian cancer (AEOC) since the implementation of a personalized approach and to validate multiple predictive models for R0 resection. METHODS: Personalized strategies...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer

Takano H, Nakajima K, Nagayoshi , Komazaki H, Suzuki J, Tanabe H, Niimi S, Isonishi S, Okamoto A

OBJECTIVE: Since there have been few large series studies to date, we investigated the relationship between Trousseau's syndrome associated with cerebral infarction and its clinical associations with ovarian cancer. METHODS: In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer

Wilson MK, Mercieca-Bebber R, Friedlander M

Health related quality of life (HRQOL) is a key priority for patients with ovarian cancer as there is significant morbidity associated with the disease and the treatment. It is therefore...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Burden of cervical neoplasia in mid-western rural Nepal: a population-based study

Thapa N, Shrestha G, Maharjan M, Lindell D, Maskey N, Shah R, Ge C, Cai H

OBJECTIVE: To assess the burden of cervical neoplasia in mid-western rural, Nepal using cytology, visual inspection with acetic acid (VIA) and visual inspection with Lugol's iodine (VILI). METHOD: A cross-sectional, population-based...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer

Ren T, Suo J, Liu S, Wang S, Shu S, Xiang Y, Lang JH

OBJECTIVES: We analyzed the chromosomal-arm-level copy number alterations (CNAs) in the cervical exfoliative cell and tissue samples by using the low-coverage whole genomic sequencing technique. METHODS: In this study, we retrospectively...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma

Micheletti L, Preti M, Cintolesi , Corvetto E, Privitera , Palmese E, Benedetto

OBJECTIVE: We aimed to identify the minimum tumor-free margin distance conferring long-term oncological safety in patients diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage IB/II vulvar squamous cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients

Lim S, Kim YH, Lee KB, Lee JM

OBJECTIVE: To determine whether drospirenone/estradiol (DRSP/E2) has an adverse effect on clinical outcomes in surgically staged International Federation of Gynecology and Obstetrics (FIGO) stage I/II endometrial cancer (EC) patients. METHODS: In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr